These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 825277)

  • 1. [Reduction of Willebrand activity in patients with chronic kidney failure].
    Kazatchkine M; Sultan Y; Bariety J; Caen J
    C R Acad Hebd Seances Acad Sci D; 1976 Jul; 283(3):287-9. PubMed ID: 825277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding in renal failure: a possible cause.
    Kazatchkine M; Sultan Y; Caen JP; Bariety J
    Br Med J; 1976 Sep; 2(6036):612-5. PubMed ID: 786433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.
    Warrell RP; Hultin MB; Coller BS
    Am J Med; 1979 Feb; 66(2):226-8. PubMed ID: 311586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding in renal failure: is von Willebrand factor implicated?
    Remuzzi G; Livio M; Roncaglioni MC; Mecca G; Donati MB; de Gaetano G
    Br Med J; 1977 Aug; 2(6083):359-61. PubMed ID: 302134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
    Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ
    Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormal factor VIII in chronic renal failure.
    Howard MA; Whitworth JA; Hendrix LE; Thomas KB; Firkin BG
    Med J Aust; 1979 Mar; 1(5):148-51. PubMed ID: 312998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.
    Lombardi R; Mannucci PM; Seghatchian MJ; Garcia VV; Coppola R
    Br J Haematol; 1981 Sep; 49(1):61-8. PubMed ID: 6791681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand Factor (VIIIVWF) in lyophilized Factor VIII concentrates.
    McCue MJ; Brossoit AD; Marmer DJ; Head DR
    Am J Hematol; 1980; 9(1):39-42. PubMed ID: 6776806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
    Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
    Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation.
    Weinstein MJ; Chute LE; Schmitt GW; Hamburger RH; Bauer KA; Troll JH; Janson P; Deykin D
    J Clin Invest; 1985 Oct; 76(4):1406-11. PubMed ID: 3932466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihaemophilic factor A activity, F VIII-related antigen and von Wilebrand factor in hepatic cirrhosis.
    Baele G; Matthijs E; Barbier F
    Acta Haematol; 1977; 57(5):290-7. PubMed ID: 403732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII--related protein on vascular intima of patients with chronic renal failure and prolonged bleeding times.
    Remuzzi G; Bertani T; Mecca G; Donati MB; de Gaetano G
    Br Med J; 1978 Jan; 1(6105):70-2. PubMed ID: 339992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF.
    Cockburn CG; de Beaufre-Apps RJ; Wilson J; Hardisty RM
    Thromb Res; 1981 Feb; 21(3):295-309. PubMed ID: 6454278
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
    Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
    Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 19. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis.
    Winter M; Needham J; Mackie I; Cameron JS
    Clin Nephrol; 1984 Dec; 22(6):307-13. PubMed ID: 6441660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.